Death and lack of functional regeneration of midbrain dopaminergic (DA) neurons, decreased DA input in the target striatum and movement anomalies characterise Parkinson's disease (PD). There is currently no cure for PD. One way to promote recovery would be to induce or enhance DA neurogenesis. Whether DA neurogenesis occurs in the adult midbrain is a matter of debate. Here, we describe the crea...

Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.

Background and Objective: Parkinson’s disease (PD) is a chronic neurodegenerative disease characterized by damages to striatal dopaminergic neurons that affects 1 to 2% of the population above 65 years of age. Olive leaf extract (OLE) is a powerful antioxidant that is considered as a source of various phenolic compounds. This study was conducted to evaluate the effects of methanolic OLE on hipp...

Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.

Parkinson disease (PD) is the second most common neurodegenerative disorder, whose prevalence 2~3% in population over 65. ?-Synuclein aggregation major pathological hallmark of PD. However, recent studies have demonstrated enhancing evidence tau pathology Despite extensive considerations, thus far, actual spreading mechanism neurodegeneration has remained elusive a PD brain. This study aimed to...

Disrupted brain iron homeostasis is a common feature of neurodegenerative disease. To begin to understand how neuronal iron handling might be involved, we focused on dopaminergic neurons and asked how inactivation of transport proteins affected iron homeostasis in vivo in mice. Loss of the cellular iron exporter, ferroportin, had no apparent consequences. However, loss of transferrin receptor 1...

objective: there is longstanding experimental and clinical evidence that supports the idea that replacement of dopaminergic (daergic) neurons can ameliorate functional disabilities of parkinson’s disease (pd). the purpose of the present study is to examine the efficacy of transplantation of rat bone marrow stromal cell (bmscs)-derived tyrosine hydroxylase-positive (th+) cells induced by depreny...

Striatal dopamine loss in Parkinson's Disease (PD) sets into play a variety of compensatory responses to help counter dopamine depletion. Most of these changes involve surviving dopamine neurons, but there are also changes in striatal medium spiny neurons (MSNs), which are the major target of dopamine axons. Among these changes are decreases in MSN dendritic length and spine density, which may ...

Although Parkinson's disease (PD) is characterized primarily by loss of nigrostriatal dopaminergic neurons, there is a concomitant loss of norepinephrine (NE) neurons in the locus coeruleus. Dopaminergic lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) are commonly used to model PD, and although MPTP effectively mimics the dopaminergic neuropathology of PD in mice, it fail...

6-hydroxydopamine, 1-methyl-4-phenyl-pyridinium (MPP+), and rotenone cause the death of dopaminergic neurons in vitro and in vivo and are widely used to model Parkinson's disease. To identify regulated genes in such models, we performed serial analysis of gene expression on neuronal PC12 cells exposed to 6-hydroxydopamine. This revealed a striking increase in transcripts associated with the unf...